# Artiva Biotherapeutics, Inc.: Form S-1/A, filed Jan 21, 2022

- Company: [Artiva Biotherapeutics, Inc.](/companies/artv.md) (CIK 1817241)
- Form: S-1/A
- Filed: 2022-01-21
- Accepted by EDGAR: Jan 21, 2022, 17:29 ET
- Period: not reported
- Accession: 0001193125-22-014926
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1817241/000119312522014926/d76940ds1a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1817241/000119312522014926/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1817241/000119312522014926/d76940ds1a.htm

Filed Jan 21, 2022.
Source: SEC EDGAR, the filing index for accession 0001193125-22-014926. Last ingested by Listed: Nov 10, 2026, 01:58 ET. No prices; not investment advice.